|
2024
|
Invention
|
Quinones for use in the treatment of red blood cell enzymopathies. Class of quinones for use in t... |
|
|
Invention
|
Quinones for use in the treatment of red blood cell enzymopathies. Classes of quinones for use in... |
|
2022
|
Invention
|
Succinate prodrug, compositions containing the succinate prodrug and uses thereof. The present in... |
|
|
Invention
|
Kl1333 for use in medicine.
The present invention relates to
i) KL1333 for us... |
|
|
Invention
|
Kl1333 for use in the treatment of fatigue. The present invention relates to i) KL1333 for use in... |
|
|
Invention
|
Kl1333 for use in medicine. The present invention relates to i) KL1333 for use in the treatment o... |
|
2021
|
Invention
|
Cell-permeable succinate compounds. The present invention provides novel cell-permeable succinate... |
|
2017
|
Invention
|
Use of sanglifehrin macrocyclic analogues as anticancer compounds. The present invention relates ... |
|
2016
|
Invention
|
Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due t... |
|
2015
|
Invention
|
Novel cell-permeable succinate compounds. The present invention provides novel cell-permeab... |
|
2013
|
Invention
|
Protected succinates for enhancing mitochondrial atp-production. 2 is independently a group accor... |
|
2012
|
Invention
|
Dosage form. There is provided inter alia a pharmaceutical dosage form for oral administration co... |
|
|
Invention
|
Macrocyclic compounds and methods for their production. There is provided inter alia compounds of... |
|
|
Invention
|
Compound and methods for its production. There is provided inter alia a compound of formula (I):
... |
|
2011
|
Invention
|
Sanglifehrin derivatives and methods for their production. There are provided inter alia compound... |
|
|
Invention
|
Cyclosporine emulsion. The present invention relates to a cyclosporine emulsion containing: i) a ... |
|
|
Invention
|
Sanglifehrin based compounds. There are provided inter alia compounds of formula (I)
useful as ... |
